Ausgabe 3/2019
Inhalt (6 Artikel)
Open Access
Original Research Article
Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study
Hui-Min Diana Lin, Chao-Lun Lai, Yaa-Hui Dong, Yu-Kang Tu, K. Arnold Chan, Samy Suissa
Open Access
Original Research Article
Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services
Ivanka Hendrix, Amy T. Page, Maarit J. Korhonen, J. Simon Bell, Edwin C. K. Tan, Renuka Visvanathan, Tina Cooper, Leonie Robson, Janet K. Sluggett
Open Access
Original Research Article
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann, Cornelia Dorn, W. Dieter Paar
Open Access
Original Research Article
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
Jean-Pierre Boissel, Frédéric Cogny, Nicholas Marko, François-Henri Boissel
Open Access
Short Communication
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication
Javier Cid Ruzafa, Sinna Pilgaard Ulrichsen, Dimitri Bennett, Vera Ehrenstein
Open Access
Short Communication
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Matthew S. Duprey, Nada S. Al-Qadheeb, Nick O’Donnell, Keith B. Hoffman, Jonathan Weinstock, Christopher Madias, Mo Dimbil, John W. Devlin